Congressman Mullin calls on FDA to resolve nationwide estradiol patch shortage

Representative Kevin Mullin has urged the FDA to take immediate action regarding a nationwide shortage of estradiol transdermal patches, a critical medication for millions of women managing menopause symptoms. A survey indicates 44% of users face significant access difficulties. Mullin requested the FDA list the patches in the Drug Shortage Database and support increased supply to alleviate patient impact.